What makes hemophilia B unique, and why does this matter? This presentation will review the specific differences between hemophilia A and B, along with their respective missing clotting factors, and how these differences may impact how your hemophilia B is managed.
We will explore how a broader view of factor activity that includes multiple measures may be appropriate when evaluating treatment. Discover why taking a closer look at hemophilia B with your doctor is important.
This Industry Symposium lunch is scheduled for Saturday from 12:00 PM - 1:30 PM in GRBCC: Grand Ballroom C. ■
There’s so much information available about gene therapy research and you might be wondering where to start? BioMarin’s Gene Therapy Learning Academy helps to turn complexity into clarity! We’ll answer your questions and share recent developments in gene therapy research – openly, accurately, and in easy-to-understand terms. Also, we can put you in touch with a BioMarin gene therapy gene-ius who can help answer your specific gene therapy research questions, point you in the direction of events and so much more.
At BioMarin’s HemDifferently.com, you have a wealth of educational resources at your fingertips, including information about gene therapy research, brochures and downloadable resources, and educational videos on a variety of topics, including:
• What are genes?
• What is gene therapy?
• How is gene therapy designed to work?
We’re dedicated to providing information that can help make gene therapy research more familiar and approachable.
Stay informed!
Sign up to connect with a BioMarin Representative and for information about events, resources, and the latest in gene therapy research at HemDifferently.com
© 2022 BioMarin Pharmaceutical Inc. All rights reserved. US-HEM-00127 7/22 ■